OQROGet OQRO Pro
Insider trade

Syndax Pharmaceuticals (SNDX)Director bought ~$91K

Keith Katkin, Director at Syndax Pharmaceuticals, bought ~$91K of Syndax Pharmaceuticals shares.

~$91K
Approx. value · 10K sh @ $9.11
100K
Holds after · shares reported
Traded
May 19, 2025
Filed
May 19, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. May 16, 2025InsiderOfficer purchased ~$106K of SNDX shares in the open market
  2. May 19, 2025 · this disclosureInsiderDirector purchased ~$91K of SNDX shares in the open market

What came next

  1. May 19, 2025InsiderDirector purchased ~$45K of SNDX shares in the open market
  2. Jul 16, 2025Insider · 2 peopleInsiders: 2 sales (~$82K)
  3. Aug 14, 2025InsiderDirector sold ~$273K of SNDX shares in the open market
  4. Aug 15, 2025InsiderDirector sold ~$298K of SNDX shares in the open market
  5. Aug 18, 2025InsiderDirector sold ~$304K of SNDX shares in the open market
  6. Sep 8, 2025Insider · Their largest sale since 2020CEO sold ~$2.58M of SNDX shares in the open market
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Syndax Pharmaceuticals

For Syndax Pharmaceuticals, OQRO holds 2 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SNDX page.

Other recent filings by Keith Katkin, Director

The full history of Keith Katkin, Director is on the profile page.

How this filing works

Other disclosures at Syndax Pharmaceuticals

Everything OQRO holds on this company is on its SNDX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data